IV Form
Safety and efficacy in pediatric patients <18y of age have not been established
Ciprofloxacin should be used as an alternative option for complicated UTI in pediatric patients aged 1-17y and for inhalation anthrax PEP
6-10 mg/kg IV q8h x10-21d (max 400 mg/dose)
10 mg/kg IV q12h x60d (max 400 mg/dose)
Oral Form
10-20 mg/kg PO q12h x10-21d (max 750 mg/dose)
15 mg/kg PO q12h x60d (max 500 mg/dose)